Deferring diagnostic evaluation of suspected deep vein thrombosis using direct oral anticoagulant or low-molecular-weight heparin as a single dose anticoagulant: A prospective real-world study in a regionwide care pathway.

MLA

Luu, Inge H. Y., et al. “Deferring Diagnostic Evaluation of Suspected Deep Vein Thrombosis Using Direct Oral Anticoagulant or Low-Molecular-Weight Heparin as a Single Dose Anticoagulant: A Prospective Real-World Study in a Regionwide Care Pathway.” Thrombosis Research, vol. 240, Aug. 2024, p. 109059. EBSCOhost, https://doi.org/10.1016/j.thromres.2024.109059.

APA

Luu, I. H. Y., Appelboom, Y., Willems, J. I. A., Gielen, R.-J. C. A. M., Lobbes, M. B. I., Külcü, K., Ten Cate, H., Peeters, J., Palmen, J., Buijs, J., Jie, K.-S. G., van Kampen, R. J. W., Mostard, G. J. M., & van Twist, D. J. L. (2024). Deferring diagnostic evaluation of suspected deep vein thrombosis using direct oral anticoagulant or low-molecular-weight heparin as a single dose anticoagulant: A prospective real-world study in a regionwide care pathway. Thrombosis Research, 240, 109059. https://doi.org/10.1016/j.thromres.2024.109059

Chicago

Luu, Inge H Y, Yael Appelboom, Jeresa I A Willems, Robbert-Jan C A M Gielen, Marc B I Lobbes, Kemal Külcü, Hugo Ten Cate, et al. 2024. “Deferring Diagnostic Evaluation of Suspected Deep Vein Thrombosis Using Direct Oral Anticoagulant or Low-Molecular-Weight Heparin as a Single Dose Anticoagulant: A Prospective Real-World Study in a Regionwide Care Pathway.” Thrombosis Research 240 (August): 109059. doi:10.1016/j.thromres.2024.109059.